Prestige Biopharma reports Ph III results for Tuznue
Clinical Research | News | 0 Comment | 24 Jun, 2019
Prestige BioPharma has announced positive top-line results from a Phase III global clinical trial (Troika) evaluati...Read more
Parexel launches an enhanced integrated outsourcing delivery model for FSP
Clinical Research | News | 0 Comment | 24 Jun, 2019
Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to marke...Read more
Asieris Completes Enrolment for US APL-1202 Phase Ib Clinical Trial
Clinical Research | News | 0 Comment | 24 Jun, 2019
Asieris, a China-based biotech company specializing in the development and commercialization of new drugs for the t...Read more
FasT CAR-19 Therapy Shows Positive Impact in Patients with (r/r) B-ALL
Clinical Research | News | 0 Comment | 21 Jun, 2019
Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage cellular immunotherapy company, on 21 June 2019, announc...Read more
Edesa Biotech receives approval to proceed with its clinical investigation
Clinical Research | News | 0 Comment | 20 Jun, 2019
Edesa Biotech, a clinical-stage biopharmaceutical company has reported that the U.S. Food and Drug Administration h...Read more
BI, Lilly announces results of new post-hoc analysis of data from the EMPA-REG OUTCOME trial
Clinical Research | News | 0 Comment | 17 Jun, 2019
Boehringer Ingelheim and Eli Lilly and Company have announced results of a new post-hoc analysis of data from the EMPA-R...Read more
Reistone Announces First Patient Dosed in Two Phase II Global Studies of SHR0302
Clinical Research | News | 0 Comment | 17 Jun, 2019
Reistone Biopharma Company Limited (Reistone), on 14 June 2019, announced dosing of the first patient in their Phase II ...Read more
Lumosa to Initiate Phase 2 Human Clinical Trial for LT3001 to treat Acute Ischemic Stroke
Clinical Research | News | 0 Comment | 14 Jun, 2019
Lumosa Therapeutics, on 13 June 2019, announced that the company is ready to commence the Phase 2 proof of concept (PoC)...Read more
China NMPA Approves Sinovant's Clinical Trial Application for Lefamulin
Clinical Research | News | 0 Comment | 14 Jun, 2019
Sinovant Sciences announced on 13 June 2019, that its Clinical Trial Application (CTA) for lefamulin has been accepted b...Read more
Terns Pharmaceuticals and Shanghai Tuosheng Biotechnology initiate TERN-101 first phase trial
Clinical Research | News | 0 Comment | 14 Jun, 2019
Terns Pharmaceuticals, Inc. and Shanghai Tuo Zhen Biological Technology Co., Ltd., on 13 June 2019, announced the launch...Read more
Dr. Reddy's announces positive results for psoriasis drug study
Clinical Research | News | 0 Comment | 11 Jun, 2019
Dr. Reddy’s has announced positive topline results from its Phase 2b study of PPC-06 (formerly referred to as...Read more
Ascentage Pharma presents new clinical data of apoptosis targeted drug candidates
Clinical Research | News | 0 Comment | 07 Jun, 2019
Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for can...Read more
CStone to initiate clinical development of CS1001 and BLU-554 in combination therapy for HCC
Clinical Research | News | 0 Comment | 06 Jun, 2019
CStone Pharmaceuticals has announced that it has received approval to initiate clinical development in C...Read more
Genentech announces meeting of primary endpoint of Ph III study
Clinical Research | News | 0 Comment | 04 Jun, 2019
Genentech, a member of the Roche Group has announced that the Phase III BLOCKSTONE study, conducted by Shionogi &am...Read more
Saluda Medical announces clinical study results of the chronic pain treatment
Clinical Research | News | 0 Comment | 03 Jun, 2019
Saluda Medical Pty Limited ("Saluda Medical") has announced data from two clinical studies evaluating the performance of...Read more
Innovent announces preliminary results of Sintilimab at ASCO
Clinical Research | News | 0 Comment | 31 May, 2019
Innovent Biologics, a world-class biopharmaceutical company that develops and commercializes high quality medicines...Read more
Pi Therapeutics announces $19.7 M Series B Financing
Clinical Research | News | 0 Comment | 30 May, 2019
Pi Therapeutics, a company dedicated to the development of novel modulators of protein degradation for cancer has announ...Read more
Up to six new HBV drugs set to launch by 2027, with China driving market growth, says GlobalData
Clinical Research | News | 0 Comment | 29 May, 2019
Within the next ten years, up to six new drugs are projected to be approved for the treatment of chronic hepatitis B vir...Read more